Cargando…

质谱成像技术及其在乳腺癌研究中的应用

The incidence of breast cancer, one of the most common malignancies affecting women, is increasing significantly worldwide. Given the rapid development of medical technology, early and effective diagnostic methods should be able to improve the survival rate and quality of life of patients suffering...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, Mengting, ZHANG, Yulu, WANG, Haojiang, LI, Ning, LI, Bo, XIAO, Hong, BIAN, Wei, CAI, Zongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Chromatography 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404019/
https://www.ncbi.nlm.nih.gov/pubmed/34227318
http://dx.doi.org/10.3724/SP.J.1123.2020.10005
_version_ 1784773516824936448
author ZHANG, Mengting
ZHANG, Yulu
WANG, Haojiang
LI, Ning
LI, Bo
XIAO, Hong
BIAN, Wei
CAI, Zongwei
author_facet ZHANG, Mengting
ZHANG, Yulu
WANG, Haojiang
LI, Ning
LI, Bo
XIAO, Hong
BIAN, Wei
CAI, Zongwei
author_sort ZHANG, Mengting
collection PubMed
description The incidence of breast cancer, one of the most common malignancies affecting women, is increasing significantly worldwide. Given the rapid development of medical technology, early and effective diagnostic methods should be able to improve the survival rate and quality of life of patients suffering from disease. However, although existing treatment options, including chemotherapy and endocrine therapies, have greatly improved the survival of patients, disease recurrence in the long term remains a challenge. Because breast cancer is a heterogeneous and complex disease, which includes several subtypes with different responses to treatment, the continual acquisition of spatial information on related biomolecules is important for accurate tracking of the tumor heterogeneity and microenvironment. At present, prognostic and predictive biomarkers, such as human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), Ki-67, progesterone receptor (PR), and programmed death-ligand 1 (PD-L1), are validated for use in the decision-making over breast cancer therapies. Mass spectrometry imaging (MSI) is a useful technique for acquiring molecular information about biological tissues, including qualitative, quantitative, and spatial distribution information, because it is based on the ion mass-to-charge ratio of the biomolecules and avoids the need for their labeling and staining. MSI can also acquire molecular information on drugs and their metabolites, as well as that on molecules related to endogenous metabolism, such as lipids, peptides, and proteins. Of the various ion sources available for MSI, the most popular are matrix-assisted laser desorption ionization, secondary ion mass spectrometry, and desorption electrospray ionization, and modifications or derivatives of these sources are still emerging. MSI-based techniques provide new ideas and directions for the molecular typing of tumors, as well as knowledge on the metabolism of related antitumor drugs. The process of MSI analysis generally involves tissue acquisition, section preparation, mass spectrometry ionization, map acquisition, and data analysis, with the most crucial step being sample handling to preserve the original chemical and location information of the analytes. The sample preparation steps are sample collection, storage, and slicing, tissue pretreatment, and matrix spraying. This review focuses mainly on the preparation of biological specimens for MSI analysis and the recent progress made in breast cancer research with this technology. With regard to sample preparation, four aspects are discussed: small-molecule samples, macromolecular samples, paraffin-embedded samples, and matrix spraying methods. To solve the difficulties associated with small-molecule sample processing, including the low extraction efficiency for certain lipids and matrix interference in the low-molecular-weight region, the addition of a cationic reagent to the extractant, the use of a new matrix, and tissue derivatization have been used. In the review of macromolecular sample processing, several different washing protocols are summarized. With regard to paraffin-embedded samples, the solutions to several common problems are reviewed. Additionally, the application of MSI to three models associated with breast cancer research is discussed, viz. cell models, animal models, and clinical tumor samples. For these models, MSI technology is used to evaluate the penetration and metabolism of antitumor agents in breast cancer, which can better reflect the malignant transformation of cells and changes in the microenvironment. With regard to lipid molecules, the use of MSI to study differences in their spatial distribution may provide a better understanding of the relationship between lipid metabolism and cancer. This review also provides important information for accurate molecular typing and drug screening in cancer research. Analytically, the tissue preparation method, tissue storage conditions, instrumentation choice, and experimental parameters have all been associated with variability in the imaging and mass-spectral qualities of MSI, thereby affecting the performance of the method. Large-scale studies using diverse sample cohorts are therefore needed to properly evaluate the robustness of MSI molecular markers and workflows for the clinical diagnosis and characterization of breast cancer variants. Our review provides strong evidence that MSI is a reliable, highly reproducible, and rapid technique for the diagnosis of breast cancer biopsies and may be useful in clinical application.
format Online
Article
Text
id pubmed-9404019
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial board of Chinese Journal of Chromatography
record_format MEDLINE/PubMed
spelling pubmed-94040192022-09-14 质谱成像技术及其在乳腺癌研究中的应用 ZHANG, Mengting ZHANG, Yulu WANG, Haojiang LI, Ning LI, Bo XIAO, Hong BIAN, Wei CAI, Zongwei Se Pu Reviews The incidence of breast cancer, one of the most common malignancies affecting women, is increasing significantly worldwide. Given the rapid development of medical technology, early and effective diagnostic methods should be able to improve the survival rate and quality of life of patients suffering from disease. However, although existing treatment options, including chemotherapy and endocrine therapies, have greatly improved the survival of patients, disease recurrence in the long term remains a challenge. Because breast cancer is a heterogeneous and complex disease, which includes several subtypes with different responses to treatment, the continual acquisition of spatial information on related biomolecules is important for accurate tracking of the tumor heterogeneity and microenvironment. At present, prognostic and predictive biomarkers, such as human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), Ki-67, progesterone receptor (PR), and programmed death-ligand 1 (PD-L1), are validated for use in the decision-making over breast cancer therapies. Mass spectrometry imaging (MSI) is a useful technique for acquiring molecular information about biological tissues, including qualitative, quantitative, and spatial distribution information, because it is based on the ion mass-to-charge ratio of the biomolecules and avoids the need for their labeling and staining. MSI can also acquire molecular information on drugs and their metabolites, as well as that on molecules related to endogenous metabolism, such as lipids, peptides, and proteins. Of the various ion sources available for MSI, the most popular are matrix-assisted laser desorption ionization, secondary ion mass spectrometry, and desorption electrospray ionization, and modifications or derivatives of these sources are still emerging. MSI-based techniques provide new ideas and directions for the molecular typing of tumors, as well as knowledge on the metabolism of related antitumor drugs. The process of MSI analysis generally involves tissue acquisition, section preparation, mass spectrometry ionization, map acquisition, and data analysis, with the most crucial step being sample handling to preserve the original chemical and location information of the analytes. The sample preparation steps are sample collection, storage, and slicing, tissue pretreatment, and matrix spraying. This review focuses mainly on the preparation of biological specimens for MSI analysis and the recent progress made in breast cancer research with this technology. With regard to sample preparation, four aspects are discussed: small-molecule samples, macromolecular samples, paraffin-embedded samples, and matrix spraying methods. To solve the difficulties associated with small-molecule sample processing, including the low extraction efficiency for certain lipids and matrix interference in the low-molecular-weight region, the addition of a cationic reagent to the extractant, the use of a new matrix, and tissue derivatization have been used. In the review of macromolecular sample processing, several different washing protocols are summarized. With regard to paraffin-embedded samples, the solutions to several common problems are reviewed. Additionally, the application of MSI to three models associated with breast cancer research is discussed, viz. cell models, animal models, and clinical tumor samples. For these models, MSI technology is used to evaluate the penetration and metabolism of antitumor agents in breast cancer, which can better reflect the malignant transformation of cells and changes in the microenvironment. With regard to lipid molecules, the use of MSI to study differences in their spatial distribution may provide a better understanding of the relationship between lipid metabolism and cancer. This review also provides important information for accurate molecular typing and drug screening in cancer research. Analytically, the tissue preparation method, tissue storage conditions, instrumentation choice, and experimental parameters have all been associated with variability in the imaging and mass-spectral qualities of MSI, thereby affecting the performance of the method. Large-scale studies using diverse sample cohorts are therefore needed to properly evaluate the robustness of MSI molecular markers and workflows for the clinical diagnosis and characterization of breast cancer variants. Our review provides strong evidence that MSI is a reliable, highly reproducible, and rapid technique for the diagnosis of breast cancer biopsies and may be useful in clinical application. Editorial board of Chinese Journal of Chromatography 2021-06-08 /pmc/articles/PMC9404019/ /pubmed/34227318 http://dx.doi.org/10.3724/SP.J.1123.2020.10005 Text en https://creativecommons.org/licenses/by/4.0/本文是开放获取文章,遵循CC BY 4.0协议 https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Reviews
ZHANG, Mengting
ZHANG, Yulu
WANG, Haojiang
LI, Ning
LI, Bo
XIAO, Hong
BIAN, Wei
CAI, Zongwei
质谱成像技术及其在乳腺癌研究中的应用
title 质谱成像技术及其在乳腺癌研究中的应用
title_full 质谱成像技术及其在乳腺癌研究中的应用
title_fullStr 质谱成像技术及其在乳腺癌研究中的应用
title_full_unstemmed 质谱成像技术及其在乳腺癌研究中的应用
title_short 质谱成像技术及其在乳腺癌研究中的应用
title_sort 质谱成像技术及其在乳腺癌研究中的应用
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404019/
https://www.ncbi.nlm.nih.gov/pubmed/34227318
http://dx.doi.org/10.3724/SP.J.1123.2020.10005
work_keys_str_mv AT zhangmengting zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT zhangyulu zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT wanghaojiang zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT lining zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT libo zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT xiaohong zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT bianwei zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng
AT caizongwei zhìpǔchéngxiàngjìshùjíqízàirǔxiànáiyánjiūzhōngdeyīngyòng